Miya Haruna

451 total citations
10 papers, 160 citations indexed

About

Miya Haruna is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Miya Haruna has authored 10 papers receiving a total of 160 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Oncology and 1 paper in Surgery. Recurrent topics in Miya Haruna's work include Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immunotherapy and Immune Responses (5 papers). Miya Haruna is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Immunotherapy and Immune Responses (5 papers). Miya Haruna collaborates with scholars based in Japan. Miya Haruna's co-authors include Hisashi Wada, Kota Iwahori, Michinari Hirata, Atsunari Kawashima, Kumiko Goto, Akiko Morimoto-Okazawa, Azumi Ueyama, Yukinori Kurokawa, Morio Nagira and Yoko Yamamoto and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Molecular Cancer Therapeutics.

In The Last Decade

Miya Haruna

9 papers receiving 159 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miya Haruna Japan	8	104	100	27	23	19	10	160
Heather MacGregor Canada	3	103 1.0×	92 0.9×	15 0.6×	20 0.9×	11 0.6×	4	143
Tomoyuki Ishiguro Japan	6	102 1.0×	48 0.5×	40 1.5×	18 0.8×	10 0.5×	10	129
Yiman Shang China	8	157 1.5×	103 1.0×	36 1.3×	32 1.4×	15 0.8×	15	185
Petros Dimitriadis Netherlands	8	113 1.1×	75 0.8×	14 0.5×	48 2.1×	13 0.7×	20	154
Shen Lao China	6	89 0.9×	52 0.5×	39 1.4×	50 2.2×	15 0.8×	11	172
Nicole Fuhrich Germany	3	56 0.5×	44 0.4×	22 0.8×	22 1.0×	8 0.4×	3	100
André Vanoli France	4	155 1.5×	121 1.2×	27 1.0×	17 0.7×	6 0.3×	6	203
Susanna Nguy United States	4	122 1.2×	102 1.0×	19 0.7×	31 1.3×	9 0.5×	9	180
Ayman Ahmed Qatar	8	81 0.8×	87 0.9×	16 0.6×	62 2.7×	29 1.5×	13	156
Marie Naigeon France	9	163 1.6×	78 0.8×	86 3.2×	34 1.5×	10 0.5×	21	212

Countries citing papers authored by Miya Haruna

Since Specialization

Citations

This map shows the geographic impact of Miya Haruna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miya Haruna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miya Haruna more than expected).

Fields of papers citing papers by Miya Haruna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miya Haruna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miya Haruna. The network helps show where Miya Haruna may publish in the future.

Co-authorship network of co-authors of Miya Haruna

This figure shows the co-authorship network connecting the top 25 collaborators of Miya Haruna. A scholar is included among the top collaborators of Miya Haruna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miya Haruna. Miya Haruna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Nagira, Morio, Ryohei Nagai, Michinari Hirata, et al.. (2023). S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells. Molecular Cancer Therapeutics. 22(9). 1063–1072. 14 indexed citations

Iwahori, Kota, Masahiro Yanagawa, Yoko Yamamoto, et al.. (2023). T cell immunity in interstitial lung disease with non-small cell lung cancer patients. Lung Cancer. 182. 107278–107278. 2 indexed citations

Ueyama, Azumi, Kunitaka Nashiki, Miya Haruna, et al.. (2023). Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell Profile. The Journal of Immunology. 211(4). 673–682. 14 indexed citations

Hirata, Michinari, Miya Haruna, Azumi Ueyama, et al.. (2022). Tumor-infiltrating ICOS⁺Effector Regulatory T-Cells in Oral Squamous Cell Carcinoma as a Promising Biomarker for Prognosis and ‘Hot’ Tumor. Anticancer Research. 42(5). 2383–2393.

Haruna, Miya, Azumi Ueyama, Yoko Yamamoto, et al.. (2022). The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer. Scientific Reports. 12(1). 5377–5377. 30 indexed citations

Nose, Yohei, Takuro Saito, Kei Yamamoto, et al.. (2022). The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer. Cancer Immunology Immunotherapy. 72(1). 169–181. 17 indexed citations

Urakawa, Shinya, Makoto Yamasaki, Tomoki Makino, et al.. (2020). The impact of ICOS+ regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapy. Cancer Immunology Immunotherapy. 70(2). 443–452. 13 indexed citations

Sawada, Masaaki, Kumiko Goto, Akiko Morimoto-Okazawa, et al.. (2020). PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer. International Immunology. 32(6). 397–405. 28 indexed citations

Haruna, Miya, Michinari Hirata, Kota Iwahori, et al.. (2020). Docetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer. Biological and Pharmaceutical Bulletin. 43(3). 399–403. 10 indexed citations

10.

Urakawa, Shinya, Makoto Yamasaki, Kumiko Goto, et al.. (2019). Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells. Cancer Immunology Immunotherapy. 68(8). 1341–1350. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact